| Literature DB >> 34397873 |
Yuye Gao1, Wu Wu1, Chunyu Liu1, Tao Liu1, Heng Xiao2.
Abstract
ABSTRACT: Laparoscopic donor hepatectomy (LDH), accepted as a minimally invasive approach, has become increasingly popular for living donor liver transplant. However, the outcomes of LDH remain to be fully clarified when compared with open living donor hepatectomy. Thus, our meta-analysis was designed to assess the efficacy of laparoscopic in comparison with conventional open donor hepatectomy.The PubMed, Cochrane, and Embase electronic databases were searched to identify the articles concerning the comparison of the efficacy of laparoscopic versus open surgery in treatment of living donor liver transplantation updated to March, 2020. The main search terms and medical Subject Heading terms were: "living donor," "liver donor," "minimally invasive," "laparoscopic surgery," and "open surgery." After rigorous evaluation on quality, the data was extracted from eligible publications. The outcomes of interest included intraoperative and postoperative results.The inclusion criteria were met by a total of 20 studies. In all, 2001 subjects involving 633 patients who received laparoscopic surgery and 1368 patients who received open surgery were included. According to the pooled result of surgery duration, the laparoscopic surgery was associated with shorter duration of hospital stay (MD = -1.07, 95% CI -1.85 to -0.29; P = .007), less blood loss (MD = -57.57, 95% CI -65.07 to -50.07; P < .00001), and less postoperative complications (OR = 0.61, 95% CI 0.44-0.85; P = .003). And the open donor hepatectomy achieved a trend of shorter operation time (MD = 30.31, 95% CI 13.93-46.69; P = .0003) than laparoscopic group. Similar results were found in terms of ALT (P = .52) as well as the AST (P = .47) peak level between the 2 groups.LDH showed the better perioperative outcomes as compared with open donor hepatectomy. The findings revealed that LDH may be a feasible and safe procedure for the living donor liver transplantation.Entities:
Mesh:
Year: 2021 PMID: 34397873 PMCID: PMC8360485 DOI: 10.1097/MD.0000000000026708
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1PRISMA flow chart of selection process to identify studies eligible for pooling.
Characteristics of the retrieved studies.
| No. of patients | Gender (male) | Donor age (mean) | ||||||
| Author year | Country | Laparoscopic | open | Laparoscopic | open | Laparoscopic | open | Laparoscopic procedure |
| Baker 2009 | American | 33 | 33 | 15 | 13 | 37 | 39.1 | Hybrid Laparoscopic |
| Thenappan 2011 | American | 15 | 15 | 7 | 6 | 33.9 | 35.7 | Hybrid Laparoscopic |
| Choi 2012 | Korea | 60 | 90 | 35 | 58 | 31.2 | 36.8 | Hybrid Laparoscopic |
| Marubashi 2013 | Japan | 31 | 79 | 13 | 54 | 35.8 | 37.8 | Hybrid Laparoscopic |
| Makki 2014 | India | 26 | 24 | 13 | 18 | 27.4 | 32.4 | Hybrid Laparoscopic |
| Soyama 2015 | American | 22 | 20 | 12 | 8 | 37.2 | 31.1 | Pure Laparoscopic |
| Suh 2014 | Korea | 14 | 268 | 1 | 206 | 24.9 | 34 | Hybrid Laparoscopic |
| Shen 2016 | China | 28 | 20 | 15 | 13 | 40.4 | 38.3 | Hybrid Laparoscopic |
| Kitajima 2017 | Japan | 153 | 77 | 36 | 43 | 42 | 43 | Hybrid Laparoscopic |
| Kurosaki 2006 | Japan | 13 | 13 | 8 | 9 | 39 | 31 | Hybrid Laparoscopic |
| Zhang 2014 | China | 25 | 25 | 13 | 18 | 27.4 | 32.4 | Hybrid Laparoscopic |
| Kim 2011 | Korea | 11 | 11 | 1 | 6 | 29.6 | 35.2 | Pure Laparoscopic |
| Soubrane 2006 | France | 16 | 14 | 10 | 9 | 29 | 32 | Pure Laparoscopic |
| Choi 2014 | Korea | 25 | 484 | 1 | 346 | 25 | 31.5 | Hybrid Laparoscopic |
| Nagai 2012 | American | 4 | 30 | 3 | 9 | 43.2 | 38.6 | Hybrid Laparoscopic |
| Ha 2013 | Korea | 20 | 20 | 11 | 17 | 25 | 29 | Hybrid Laparoscopic |
| Samstein 2015 | American | 22 | 20 | 12 | 8 | 37.2 | 31.1 | Pure Laparoscopic |
| Gautier 2018 | Russian | 35 | 35 | 6 | 19 | 28.6 | 29.1 | Pure Laparoscopic |
| Hong 2019 | Korea | 8 | 18 | 8 | 16 | 41 | 37 | Pure Laparoscopic |
| Park 2019 | Korea | 72 | 72 | 40 | 43 | 28.5 | 29.5 | Pure Laparoscopic |
Figure 2Pooled analysis of operative time.
Figure 3Pooled analysis of blood loss.
Figure 4Synthesis of results in terms of the peak level of AST.
Figure 5Synthesis of results in terms of the peak level of ALT.
Figure 6Pooled analysis of the length of hospital stay.
Figure 7Pooled analysis of complications rate.